(VIANEWS) – Shares of MEDISTIM (Oslo Børs Benchmark Index_GI: MEDI.OL) jumped 9.13% to kr239.00 at 13:40 EST on Wednesday, after two successive sessions in a row of losses. Oslo Børs Benchmark Index_GI is jumping 0.2% to kr1,243.41, following the last session’s upward trend. This seems, as yet, a somewhat positive trend trading session today.
MEDISTIM’s last close was kr221.00, 33.03% below its 52-week high of kr330.00.
About MEDISTIM
Medistim ASA develops, produces, services, leases, and distributes medical devices for cardio-vascular surgery in the United States, Europe, Asia, and internationally. It offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and transit TTFM in a single system for vascular surgery; and imaging probes for intraoperative use. The company also provides various flow probes, such as QuickFit TTFM probes to accurately measure blood volume flow intraoperatively in various range of surgical applications; Vascular TTFM probes for enhancing surgical outcomes; and doppler probes that are used on the surface of the heart/vessel to search for intramural coronary arteries or to locate the position and quantify the degree of a stenosis. In addition, it distributes and sells third party medical equipment. The company was incorporated in 1984 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, MEDISTIM has a trailing twelve months EPS of kr5.31.
PE Ratio
MEDISTIM has a trailing twelve months price to earnings ratio of 45.01. Meaning, the purchaser of the share is investing kr45.01 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 31.12%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 14.1%, now sitting on 458.69M for the twelve trailing months.
Earnings Before Interest, Taxes, Depreciation, and Amortization
MEDISTIM’s EBITDA is 82.93.
Yearly Top and Bottom Value
MEDISTIM’s stock is valued at kr239.00 at 13:40 EST, way below its 52-week high of kr330.00 and way above its 52-week low of kr184.80.
More news about MEDISTIM (MEDI.OL).
